Serge Saxonov, Chief Executive Officer at 10x Genomics, Inc. (TXG), sold 5,000 shares at $24.56 ($123K) on 2026-04-14, disclosed to the SEC on 2026-04-16.
Scheduled sale ($123k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TXG | SELL | 2026-08-26 | $1.2M | — | Filing → |
| TXG | SELL | 2026-06-24 | $1.0M | — | Filing → |
| TXG | SELL | 2026-05-27 | $709K | — | Filing → |